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Abstract 
Purpose: To assess knowledge of and intervention for malaria in pregnancy among immediate 
postpartum women, as well as the impact of malaria on some specific birth outcomes.  
Methods: A cross-sectional study in which 358 immediate postpartum women were recruited in the 
labour and maternity wards of University Benin Teaching Hospital, Benin City, Nigeria. Information on 
demographics, knowledge of malaria, and utilization of malaria interventions were assessed. 
Immediately after expulsion of placentae, both maternal and placental blood samples were collected 
from a subset (236) of the study group for parasitaemia and haematocrit determination.  
Results: The mean age of the women was 29.5 ± 4.55 years. Poor knowledge of adverse effects of 
malaria during pregnancy was observed. Using an arbitrary scale, low, average and high knowledge of 
malaria were recorded in 22.4, 50.3 and 27.3 % of the respondents, respectively. Use of insecticide-
treated net (ITN) was reported by 48.9, 19.1 and 14.3 % of women with high, average and low 
knowledge of malaria respectively (p = 0.004) while there was no statistical difference in the use of 
sulphadoxine/pyrimethamine (IPTp-SP) among the different levels of knowledge of malaria as its 
practice was reported by 61, 70 and 78.7 % of women with high, average, and low knowledge of 
malaria, respectively, (p = 0.078). Incidence rates of parasitaemia of 4.0, 1.6 and 6.25 % were obtained 
using peripheral microscopy, placental microscopy and peripheral rapid diagnostic test (RDT), 
respectively. Maternal infection was significantly associated with low birth weight (p = 0.020, peripheral 
microscopy; p = 0.020, placental microscopy) and maternal anaemia (p = 0.009, peripheral microscopy; 
p = 0.000, peripheral RDT).  
Conclusion: Knowledge gap still exists with regard to malaria and its interventions among mothers. 
Knowledge of malaria significantly influences the use of insecticide-treated bed nets. The negative 
impact of malaria infection during pregnancy is maternal anaemia and low birth weight infants.  
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Plasmodium falciparum malaria in pregnancy is a 
major public health problem in sub-Saharan 
Africa, posing serious health concern to pregnant 
women and the fetus. It is often asymptomatic 
and severe, as it often progresses undetected to 
complicated malaria [1]. The clinical 
consequences of the disease include maternal 
anaemia, low birth weight, preterm delivery, and 
by extension, increased perinatal and infant 
mortality [2,3]. Consequently, the protection of 
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pregnant women living in malaria-endemic 
countries has become of particular interest to 
many international and national malaria control 
programmes. The World Health Organization 
recommends a three-prong approach to the 
control of malaria in pregnancy [4]. These are the 
practice of sleeping under insecticide-treated 
mosquito bed nets (ITNs) daily, intermittent 
preventive treatment in pregnancy using an 
effective anti-malarial drug e.g. sulphadoxine-
pyrimethamine (IPTp-SP), and effective 
management of clinical cases of malaria in 
pregnancy. Despite these recommendations 
however, there are reports indicating poor 
utilization of these interventions, particularly the 
use of ITNs and IPTp-SP [5,6]. The consequence 
of low utilization of aforementioned malaria 
control measures would be unresolved burden of 
malaria in pregnancy in endemic countries, 
including Nigeria. This study was undertaken in 
order to re-assess malaria situation during 
pregnancy in the light of recent attention by both 
local and national governments. Therefore, the 
objectives of this study were to assess 
knowledge of and intervention for malaria in 
pregnancy, as well as the impact of malaria on 
some specific birth outcomes among immediate 
postpartum women who delivered their babies in 




The study was a non-interventional and cross-
sectional study designed to assess the 
knowledge of, and interventional practices for 
malaria in pregnancy, as well as to determine the 
clinical outcomes in women diagnosed of malaria 
at parturition. The study was carried out between 
1st April and 31st August 2011 at the University 
of Benin Teaching Hospital, Benin City, Edo 
State, Nigeria. The period of the study was 
during the high malaria transmission season in 
the area. This area had earlier been reported to 
experience monthly variations in delivery rates 
with peak delivery rates in April – May and 
October and lowest rates in July – August and 
December [7]. Women who delivered their 
babies (dead or alive) were approached 
immediately after delivery and given information 
regarding research objectives and were assured 
of confidentiality of personal information. Only 
those women who gave informed written or 
verbal consent and satisfied the inclusion criteria 
were enrolled in the study. The study protocol 
was reviewed and approved by the Ethical 
Review Committee of the University of Benin 
Teaching Hospital (Protocol number: ADM / E. 
22A / VOL. VII / 392).  
 
A total of 358 women were recruited 
consecutively during week-days into the 
knowledge and practice (KP) study. Excluded 
from the study were health care personnel, 
mentally unstable mothers and women who had 
history of allergy to sulphur-containing drugs. 
The women were interviewed with the aid of a 
pre-tested structured questionnaire (administered 
within 24 hours of delivery) which assessed the 
women’s knowledge of malaria in pregnancy and 
practices of malaria control measures. Relevant 
information on socio-demographic characteristics 
and obstetric history of the participants were 
extracted from the women’s medical case files.  
 
The assessment of knowledge of malaria 
consisted of questions on four areas: 
transmission of malaria, knowledge of risk, 
preventive measures (the two recommended 
measures) and consequences of disease during 
pregnancy (any 3 consequences); appropriate 
responses to the questions corresponded to 
scores 1, 1, 2 and 3 respectively, as described 
elsewhere [8]. The range of possible scores was 
0 – 7. An arbitrary scale was used in categorizing 
the respondents. A mid-point of 3 – 4 was termed 
average knowledge. Below the mid-point was 
classified as “low knowledge score” while above 
was classified as “high knowledge score”. 
Laboratory investigations for malaria at 
parturition consisted of peripheral microscopy, 
peripheral rapid diagnostic test (RDT) for 
parasite histidine rich protein 2 (HRP-2), and 
placental microscopy. Both maternal peripheral 
and placental (incision method) blood samples 
were collected immediately after delivery from a 
subset of the study participants (n = 224).  Only 
study participants who gave consent for their 
blood samples to be collected when approached 
during labour, and who delivered while the 
investigator was present at the labour wards 
were sampled for laboratory investigation for 
malaria. This was important to avoid coagulation 
of the placental blood. Thick and thin blood 
smears of finger-prick peripheral blood sample 
from each woman were prepared on a slide for 
microscopic examination. Same procedure was 
done using the placental blood samples. 
Thereafter, the blood smears were air-dried and 
subsequently stained with 10 % solution of 
freshly prepared Giemsa stain at pH 7.2 for 
about 15 min. The stained films were read by 
independent two microscopists. Detection of 
parasite HRP-2 in the maternal peripheral blood 
samples was done using a commercially 
available kit (SD Bioline Malaria Ag P. f test, 
Korea), according to the manufacturer’s 
instruction. Also, samples from the maternal 
finger-prick blood were used for haematocrit 
determination. Excluded from the study were 
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women who received blood and or blood 
products later than one week prior to their 
delivery, women who were diabetic during the 
pregnancy, or had physical trauma, or had 
multiple pregnancy or are known homozygous 
sickle cell disease patients for obvious reasons. 
Pregnancy outcomes that were assessed were 
low birth weight (LBW), defined as a birth weight 
<2500 g; preterm delivery, defined as gestational 
period < 37 weeks, and maternal anaemia, 
defined as packed cell volume < 30 %. 
Gestational period was assessed using the 
woman’s last menstrual period (LMP) and 




The data were entered in Microsoft Excel data 
sheets, cross checked and transferred, and 
analyzed using SPSS for Windows version 16.0 
(SPSS, Atlanta, GA, USA). Descriptive statistics 
were carried out for continuous variables (mean 
± SD), while categorical variables were treated 
as frequencies and percentages. Chi-squared 
test was used to compare proportions of 
categorical variables and to determine the 
statistical significance between the variables, 
while between groups comparisons were 





Demographics of study participants 
 
Out of the 358 postpartum women who were 
administered questionnaires, complete data were 
obtained for 344 women giving a response rate 
of 96.1 %. The ages of the respondents ranged 
from 18 – 45 years with a mean age of 29.5 ± 
4.55 year. Women within 26 – 35 years age 
groups (73.2 %) constituted significant proportion 
of the respondents. The study group was 
predominantly made up of monogamously 
married women (94.2 %). More than two-fifths of 
the study group were primiparous women. All the 
women were formally educated. The 
characteristics of the participants are shown in 
Table 1. The mean duration of pregnancy and 
mean weight of the babies were 274.40 ± 12.64 
days and 3.09 ± 0.52 kg, respectively. 
 
Knowledge of malaria in pregnancy 
 
A mean value of knowledge of malaria score of 
3.53 ± 1.397 was obtained. The proportions of 
women with low, average and high knowledge 
were 22.4, 50.3 and 27.3 %, respectively. 
 
On assessment of the cause of malaria, about 80 
% (276) of the respondents attributed the cause 
of malaria to bites from infected mosquito only, 
while about 14 % (48) of the respondents agreed 
that malaria could arise from bites from infected 
mosquito as well as other causes, such as, dirty 
environment, eating unclean food and drinking 
contaminated water, excessive exposure to 
sunlight, and excessive stress.   
 
Table 1: Characteristics of participants (n = 344) 
 
Variable No. % 
Age (years) 
15 – 20  
21 – 25 
26 – 30 
31 – 35 
36 – 40 















Married     
Single 
Unmarried but living with a 






















Primary education   
Secondary education     












Classic business woman 















An appreciable proportion of the women (88.7 %, 
305/344) agreed that pregnancy increases the 
risk of malaria; while the remaining 11.3 % 
(39/344) had a contrary opinion (25 women 
agreed that pregnancy does not increase risk of 
malaria, while 14 women agreed that the risk is 
equal in both pregnant and non-pregnant 
women). However, 47.2 % (144/305) of the 
women who agreed that pregnancy increases the 
risk of malaria had no reason for their response. 
The reasons given by other women for increased 
susceptibility to malaria during pregnancy are 
decreased maternal immunity (22.4 %), weak 
body and inadequate care of oneself (19.5 %), 
physiological changes due to foetal presence 
(7.6 %), anorexia and vomiting (2.2 %), and bad 
blood and water in the maternal circulation (0.9 
%). 
 
The lowest knowledge scores related to the 
impact of maternal malaria on the health of the 
foetus; about 50 % of the respondents failed to 
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recognize any potential consequence of maternal 
malaria on the foetus. Only 34.6 % (119), 12.2 % 
(42) and 2.9 % (10) of the women mentioned 
one, two and three adverse effects of malaria in 
pregnancy (MiP), respectively. Of all the 
consequences of MiP that were mentioned, 
maternal anaemia was most cited (49.1 %, n = 
84/171). Other consequences of MiP that were 
mentioned by the respondents were jaundice in 
new born babies (31.6 %), pregnancy loss (25.1 
%), malaria in baby (17 %), low birth weight (8.2 
%), newborn death (4.1 %) and intrauterine feotal 
death (1.8 %).  
 
Of the 344 respondents, only 109 (31.7 %) 
women knew that both intake of 
sulphadoxine/pyrimethamine-based intermittent 
preventive therapy (IPTp-SP) and the use of 
insecticide-treated bed nets (ITNs) are the two 
best anti-malarial control measures during 
pregnancy. A significant proportion of the 
respondents (77.6 %) were aware of ITNs than 
IPTp-SP (41.3 %). Other interventions that were 
mentioned by the respondents for effective 
control of MiP include: indoor insecticide 
spraying (16 %; n = 55), healthy eating and 
drinking habits (16.3 %; n = 56), environmental 
sanitation (9.0 %; n = 31), and use of local herbs 
(2.9 %; n = 10). A greater proportion of the 
respondents (37.2 %; n = 128) believed that 
netted doors and windows are effective 
preventive measures against pregnancy.  
 
Reported anti-malarial interventions during 
pregnancy  
 
The study participants used eight different anti-
vector measures – (insecticide treated bed net, 
untreated bed net, indoor insecticide spraying, 
door and window nets, repellant creams and 
soap, insecticide coils, local herbs and protective 
wears). Of the 8 anti-vector measures that were 
identified, door and window nets had the highest 
rate of use (90.4 %). The respondents’ opinion of 
best anti-malarial measure for malaria in 
pregnancy was at variance with what they 
practiced during pregnancy (Table 2). 
 
Despite the high level of awareness of 
insecticide-treated bed nets (ITNs) among the 
respondents, the utilization rate among the 
respondents was poor (26.2 %, OR: 5.432; CI: 
2.27 − 12.99). Intermittent preventive treatment 
using sulphadoxine/pyrimethamine (IPTp-SP) 
was utilized by a proportion of women higher 
than the proportion that knew about it (70.3 %, 
OR: 1.269; CI: 0.79 − 2.04). The IPTp-SP was 
reportedly not taken at all by 29.7 % (102) of the 
women. Notwithstanding the foregoing, 
appropriate use of these interventions was 
further recorded in a smaller proportion of the 
women. Only 6.7 % (23) of the interviewed 
women slept under ITNs daily, while 32 % (110) 
of the women utilized more than one dose of 
IPTp-SP. Only 10 (2.9 %) women utilized both 
daily ITN and ≥ two doses of IPTp-SP. The mean 
gestational period (weeks) of intake of first and 
second doses of IPTp-SP were 24 and 32, 
respectively. 
 
Table 2: Respondents’ opinion of best anti-malarial 
measures versus actual practice during pregnancy (n 
= 344) 
 










ITNs 267 (77.6) 90 (26.2) 
IPTp – SP  142 (41.3) 242 (70.3) 
ITNs + IPTp-SP  109 (31.7) 22 (6.4) 
Door and window nets                                                    128 (37.2) 311 (90.4) 
Indoor insecticide spraying  55 (16) 282 (82) 
Local herbs                                                                   10 (2.9) 10(2.9) 
Healthy eating/drinking habits  56 (16.2) − 
Environmental sanitation  31 (9) − 
Untreated bed net     − 11 (3.2) 
Insecticide coil                                                              − 3 (0.9) 
Repellant cream and soap − 15 (4.4) 
Protective wears                                                           − 107 (31.1) 
Non-SP prophylaxis                                                     35 (10.2) 
*Percentage is more than 100 % because some 
respondents used more than one anti-malarial 
intervention. N = number of women; ITN = insecticide-
treated bed nets, IPTp-SP = intermittent preventive 
treatment in pregnancy using sulphadoxine-
pyrimethamine 
 
Reasons given by the women for non-use of 
ITNs during the immediate past pregnancy were: 
lack of awareness (5.9 %), believed that door 
and window nets were sufficient control 
measures (17.7 %), inaccessibility (12.6 %), 
disliked by the husband (8.7 %), meant for 
children (12.6 %), lack of fund (17.7 %), causes 
discomfort and sweating (11.8 %), unnecessary 
because they believed they have immunity (3.1 
%), did not have mosquitoes in the house (1.2 
%), and difficulty to properly fix the net at home 
(8.7 %). Among the IPTp-SP defaulters were 
women who believed that the drug is not safe in 
pregnancy (n = 27), women who said that the 
intake of the drug is unnecessary since they had 
no malaria symptoms at the time they were given 
the medication (n = 15) and those who had late 
booking for antenatal care services, or presented 
at term or in labour (n = 60).  
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Clinical outcomes among users of different 
anti-malarial interventions during pregnancy 
 
The practice of intake of at least 2 doses of IPTp-
SP and sleeping in ITNs daily during pregnancy 
was associated with good maternal and neonatal 
outcomes (Table 3). However, women that used 
other anti-malarial interventions had varying 
degrees of poor pregnancy outcomes. The 
poorest clinical outcomes – highest frequency of 
incidence of clinically diagnosed malaria during 
pregnancy, number of babies with LBW and 
preterm delivery were observed among those 
women that used untreated door and window 
nets only. 
 
Pregnancy outcomes and interventional 
practices associated with knowledge of 
malaria 
 
Between the three levels of knowledge of 
malaria, there was no significant difference in the 
mean birth weight and mean duration of 
pregnancy in days (Table 4). The mean maternal 
PCV was significantly high in mothers with high 
KoM (25.22 ± 16.795, p = 0.003).  Use of ITN 
was reported by 48.9 %, 19.1 % and 14.3 % of 
women with high, average and low knowledge of 
malaria respectively (p = 0.004). On the other 
hand, there was no statistical difference in the 
use of IPTp-SP among the different levels of 
knowledge of malaria as its practice was 
reported by 61 %, 70 % and 78.7 % of women 
with high, average, and low knowledge of 
malaria, respectively, (p = 0.078). 
 
Incidence of, and pregnancy outcomes 
associated with malaria at parturition  
 
By microscopy, P. falciparum malaria-positive 
results were obtained in 9/224 (4.0 %) and 4/224 
(1.6 %) peripheral and placental blood samples, 
respectively. Peripheral RDT gave malaria-
positive results for 14/224 (6.25 %) blood 
samples. Only three peripheral blood samples 
were positive by both microscopy and RDT. The 
peripheral blood films of the 4 women with 
placental infection all showed negative results by 
both microscopy and RDT. Overall, 24 women 
were malaria-positive. This gave a rate of P. 
falciparum malaria at parturition of 10.7 %. 
 
All women who tested positive for malaria had 
average or high knowledge of malaria in 
pregnancy. However, they had poor adherence 
to the recommended preventive measures for 
malaria in pregnancy – sleeping under ITNs daily 
and intake of at least two doses of IPTp-SP. Only  
 
Table 3: Outcomes observed among users of different anti-malarial interventions during pregnancy 
 
Anti-malarial intervention No. of babies 
with LBW 
 N (%) 
Preterm 







Daily ITN use only (n꞊8) 2(25) 2(25) 5(62.5) 1(12.5) 






Regular indoor insecticide spraying 
only (n꞊11) 
1(9.1) 0(0) 9(81.8) 3(27.3) 










Daily ITN use + at least 2 doses of 








MiP = malaria in pregnancy; LBW = low birth weight; ITN = insecticide-treated bed nets, IPTp-SP = intermittent 
preventive treatment in pregnancy using sulphadoxine-pyrimethamine; N = number of women who experienced 
the poor outcome 
 
Table 4: Comparison of pregnancy outcomes between the three levels of knowledge of malaria 
 
                                                                     Level of knowledge of malaria 
Pregnancy outcome 
 
Low knowledge Average 
knowledge 
High knowledge P-value 
Mean birth weight (kg) 
Mean duration of pregnancy (days) 
Mean PCV (%) of respondentsa 
2.98 ± .551 
274.12 ± 13.768 
22.27 ± 17.039 
3.1046 ± 0.534 
274.92 ± 11.883 
21.80 ± 17.680 
2.9773 ± .551 
273.68 ± 13.132 




aNumber of respondents = 224; values are presented as mean ± SD; statistical analysis is based on one-way 
ANOVA; p < 0.05 was considered statistically significant; PCV = parked cell volume 
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Table 5: Comparison of pregnancy outcomes among malaria-positive and malaria-negative mothers identified by 





















2.82 ± 0.45 
 




30.33 ± 3.35 
 









2.92 ± 0.37 3.13 ± 0.40 
 
0.088 28.36 ± 5.41 
 











2.44 ± 0.28 3.1± 0.39 0.000 32.00 ± 3.16 35.14 ± 0.36 0.256 280.25±4.99 275.98 ± 9.98 0.395 
Data are mean ± SD; statistical analysis is based on Student’s t-test; p < 0.05 was considered statistically 
significant; PCV = packed cell volume; RDT = rapid diagnostic test 
 
5 women used ITNs while 9 women took only 
one dose of SP. None of the women took second 
dose of IPTp-SP. Almost all the women (23/24) 
mentioned that they had untreated nets fixed on 
the doors and windows at home. 
 
Overall, the birth weight of the babies born to the 
women that were assessed (n = 224) ranged 
from 2 to 4.25 kg (3.14 ± 0.37 kg). The maternal 
PCV and duration of pregnancy ranged from 17 
to 52 % (22.84 ± 17.31%) and 205 to 295 (274 ± 
12.64) days, respectively. 
 
Eight women out of the 9 women who had 
malaria on peripheral blood examination 
delivered live babies whose birth weights ranged 
from 2.25 – 3.35 kg (mean weight ± standard 
deviation). The remaining mother had an 
intrauterine foetal death of a 3.6 kg baby. Five 
women out of the nine women with malaria 
detectable microscopically in peripheral blood 
had PCV < 30 %. Only 1 woman out of the 14 
women with RDT-positive results had a baby with 
LBW, while 9 women out of them had maternal 
PCV < 30 %. Two women out of the 3 women 
who tested positive by both peripheral 
microscopy and RDT had babies with LBW. The 
third woman had an intrauterine foetal death. 
Only 1 out of the 4 women with placental malaria 
had low maternal PCV of 29 %. However, LBW 
was recorded in three women. Table 5 shows 
that maternal infection was significantly 
associated with low birth weight, LBW (p = 0.020, 
peripheral microscopy; p = 0.020, placental 
microscopy), and maternal anaemia (p = 0.009, 
peripheral microscopy; p = 0.000, peripheral 
RDT). Although maternal infection was not 
significantly associated with preterm delivery, yet 
the mean duration of pregnancy (days) was 
lower among the malaria-positive mothers 
confirmed by peripheral microscopy and RDT 




Malaria remains one of the parasitic diseases of 
immense public health burden particularly in sub-
Saharan Africa. This study reveals the existence 
of gaps in the knowledge of malaria in 
pregnancy, low rates of utilization of the 
recommended malaria preventive measures 
during pregnancy (below global targets) as well 
as poor maternal and neonatal outcomes 
associated with malaria in pregnancy.  
 
The finding of women’s poor knowledge of 
consequences of maternal malaria on the foetus 
despite having average or high general 
knowledge of malaria in pregnancy suggests 
need for adequate malaria education among 
women. Similar studies had reported low 
knowledge of foetal health impact of malaria in 
pregnancy among pregnant women [8,9]. 
Furthermore, a higher number of respondents 
were aware of ITN than IPTp-SP as preventive 
strategy for malaria in pregnancy. A comparable 
result was obtained in a similar study carried out 
among pregnant women presenting for antenatal 
care in Uyo, Nigeria [5]. Despite the high level of 
awareness of insecticide-treated bed nets (ITNs) 
among the respondents, the utilization rate was 
poorer than that of IPTp-SP. Thus, the popularly 
accepted fact that poor knowledge or awareness 
of anti-malarial interventions significantly 
accounts for the low utilization rates of these 
measures is contentious. Though a majority of 
the women used IPTp-SP, the knowledge of the 
rationale for the use of the drug during 
pregnancy in these women was low. A factor 
noted to have contributed to the high utilization 
rate of IPTp-SP at the study site was the routine 
prescription and dispensing of sulphadoxine-
pyrimethamine to the pregnant women during 
their antenatal clinic visits. Although a large 
proportion of the women utilized first dose of 
IPTp-SP at some point during the pregnancy, 
less than half of them took subsequent doses. 
Failure of the women to return at subsequent 
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scheduled antenatal visits, resulting in 
incomplete intake of IPTp-SP doses might have 
been the contributing factor. It was also observed 
that intake of IPTp-SP doses, particularly when 
the second and or third dose was taken, 
occurred rather late into the pregnancy. This 
might have contributed to the low incidence rate 
of malaria at parturition. However, the delayed 
use of IPTp-SP during pregnancy may not 
adequately protect the growing foetus against 
malaria during the time of maximum foetal 
growth. Besides the ITNs and IPTp-SP, women 
used other anti-malarial control measures during 
the immediate past pregnancy which did not 
confer effective protection against adverse 
effects of malaria. None of the women who 
utilized both daily ITN and at least 2 doses of 
IPTp-SP had any form of poor maternal or 
neonatal outcome. These findings further support 
the benefits of the two interventional measures 
against malaria in pregnancy. 
 
The rate of peripheral malaria obtained in this 
study was comparable to the rate reported in a 
recent Nigerian study [10]. However, varying 
rates of peripheral parasitaemia ranging from 7.5 
% − 60 % had been reported in previous studies 
in different parts of Nigeria [11-13]. In addition, 
such wide variations had been observed in 
recent studies from other African countries, such 
as Kenya (ranging from 9.4 % to 20.1 %) [14,15]; 
and Cameroun (ranging from 15.9 % to 32.8 %) 
[16,17]. It is worthy of note that neither 
microscopy of peripheral blood nor HRP2 
detection test in the peripheral blood could detect 
any of the P. falciparum infections confirmed by 
placental microscopy. The possibility of existence 
of placental parasitemia in the absence of 
peripheral blood parasitemia, and even the 
persistence of parasites in the placenta after 
initiation of anti-malarial treatment had been 
documented in previous report (1997) [18]. In this 
study, maternal malaria identified by peripheral 
microscopy and placental infection were 
associated with low birth weight. This result is 
consistent with the findings from previous studies 
though, Singer et al (2004) reported no 
association between peripheral parasitaemia and 
prevalence of low birth weight [19,20]. Positive 
peripheral RDT, as well as, peripheral 
microscopy were found to be significantly 
associated with reduced maternal packed cell 
volume (PCV). The result was similar to those of 
previous studies [21,22]. In the present study, we 
did not find association between maternal 
malaria and preterm delivery, which is similar to 
a previous report by Mokuolu et al [21]. However, 
some other studies had reported existence of 
such an association between maternal malaria 
and preterm delivery [23].  
Limitations of the study 
 
This study has limitations. The first limitation is 
recall bias that might be present during the 
interview as some women might not have 
accurately recalled the anti-malarial control 
measures they used during pregnancy. The 
second limitation is the small sample size that 




Knowledge of malaria significantly influences the 
use of insecticide treated bed nets, but not 
intermittent preventive treatment by pregnant 
women. Considering the health burden of malaria 
during pregnancy, we recommend effective 
health educational programmes for proper public 
enlightenment on control of the disease. There 
may be need to review current strategies of 
educating the community about malaria control 




The authors thank the management and staff of 
the labour and maternity wards of the University 
of Benin Teaching Hospital, especially the 
nurses, who were of great assistance during data 
collection. All the women who participated in the 





1. Desowitz RS, Alpers MP. Placental Plasmodium 
falciparum parasitaemia in East Sepik (Papua New 
Guinea) women of different parity: the apparent 
absence of acute effects on mother and foetus. Ann 
Trop Med Parasitol 1992; 86 (2): 95-102. 
2. Steketee RW, Nahlen BL, Parise ME, Menendez C. The 
burden of malaria in pregnancy in malaria-endemic 
areas. Am J Trop Med Hyg 2001; 64(suppl): 28-35. 
3. Guyatt HL, Snow RW. The epidemiology and burden of 
plasmodium falciparum-related anaemia among 
pregnant women in sub-Saharan Africa. Am J Trop 
Med Hyg 2001; 64(suppl): 36-44. 
4. WHO: Framework for developing, implementing and 
updating national antimalarial drug policy: A guide for 
country malaria control programmes. WHO Regional 
Office for Africa, Brazzaville. AFR/MAL/03.02 World 
Health Organization, 2003. 
5. Abasiattai AM, Etukumana EA, Umoiyoho AJ. Awareness 
and Practice of malaria prevention strategies among 
pregnant women in Uyo, South South Nigeria. 
Internet J Gynecol Obstet 2009; 11(1). 
6. Tongo OO, Orimadegun AE, Akinyinka OO. Utilisation of 
malaria preventive measures during pregnancy and 
Obieche et al 
Trop J Pharm Res, June 2015; 14(6): 1110  
 
birth outcomes in Ibadan, Nigeria. Pregnancy and 
Childbirth. 2011; 11: 60-67. 
7. Enabudoso EJ, Okpighe AC, Gharoro EP, Okpere EE. 
Delivery rate in Benin City, Nigeria: Are there 
seasonal variations? Nig J Clin Pract 2011; 14 (2): 
129-131.   
8. Nganda RY, Drakeley C, Reyburn H, Marchant T. 
Knowledge of malaria influences the use of 
insecticide treated nets but not intermittent 
presumptive treatment by pregnant women in 
Tanzania. Malar J 2004; 3: 42-49. 
9. Enato EFO, Okhamafe AO, Okpere EE. A survey of 
knowledge, attitude and practice of malaria 
management among pregnant women from two 
health care facilities in Nigeria. Acta Obstet et 
Gynecol Scand 2007; 86: 33-36.  
10. Agomo CO, Oyibo WA, Anorlu RI, Agomo PU. 
Prevalence of malaria in pregnant women in Lagos, 
South-West Nigeria. Korean J Parasitol 2009; 47 (2): 
179-183. 
11. Okwa OO. The status of malaria among pregnant 
women: a study in Lagos, Nigeria. Afr J Reprod 
Health 2003; 7: 77-83. 
12. VanderJagt TA, Ikeh EI, Ujah IO, Belmonte J, Glew RH, 
VanderJagt DJ. Comparison of the OptiMAL rapid 
test and microscopy for detection of malaria in 
pregnant women in Nigeria. Trop Med Int Health 
2005; 10: 39-41.   
13. Enato EFO, Okhamafe AO, Okpere EE, Oseji FI. 
Prevalence of malaria during pregnancy and 
antimalarial intervention in an urban secondary health 
care facility in Southern Nigeria. Med Princ Pract 
2007; 16: 240-243.   
14. Malhotra I, Dent A, Mungai P, Muchiri E, King CL. Real-
time quantitative PCR for determining the burden of 
Plasmodium falciparum parasites during pregnancy 
and infancy. J Clin Microbiol 2005; 43(8): 3630-3635.  
15. van Eijk AM, Ayisi JG, ter Kuile FO, Misore AO, Otieno 
JA, Rosen DH, Kager PA, Steketee RW, Nahlen BL. 
Risk factors for malaria in pregnancy in an urban and 
peri-urban population in western Kenya. Trans R Soc 
Trop Med Hyg 2002; 96: 586-592.    
16. Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke 
RF. Risk factors for placental malaria and its effect on 
pregnancy outcome in Yaoundé, Cameroon. Am J 
Trop Med Hyg 2005; 72: 236-242. 
17. Akum AE, Kuoh AJ, Minang JT, Achimbom BM, 
Ahmadou MJ, Troye-Blomberg M. The effect of 
maternal, umbilical cord and placental malaria 
parasitaemia on the birth weight of newborns from 
South-western Cameroon. Acta Paediatr 2005; 94(7): 
917-923.    
18. Sartelet H, Milko-Sartelet I, Garraud O, Picot S. 
Plasmodium falciparum persist in the placenta after 
three days’ treatment with quinine. Trans R Soc Trop 
Med Hyg 1997; 91: 431. 
19. Singer LM, Newman RD, Diarra A, Moran AC, Huber CS, 
Stennies G, Sirima SB, Konate A, Yameogo M, 
Sawadogo R, Barnwell JW, Parise ME. Evaluation of 
a malaria rapid diagnostic test for assessing the 
burden of malaria during pregnancy. Am J Trop Med 
Hyg 2004; 70(5): 481-485.   
20. Wort UU, Warsame M, Brabin B. Birth outcomes in 
adolescent pregnancy in an area with intense malaria 
transmission in Tanzania. Acta Obstet Gynecol 
Scand 2006; 85(8): 949-954. 
21. Mokuolu OA, Falade CO, Orogade AA, Okafor HU, 
Adedoyin OT, Oguonu TA, Dada-Adegbola HO, 
Oguntayo OA, Ernest SK, Hamer DH, Callahan MV. 
Malaria at Parturition in Nigeria: Current status and 
delivery outcome. Infect Dis in Obstet Gynecol 2009; 
doi:10.1155/2009/473971. 
22. Egwunyenga OA, Ajayi JA, Duhlinska-Popova DD. 
Malaria in pregnancy in Nigerians: seasonality and 
relationship to splenomegaly and anaemia. Indian J 
Malariol 1997; 34(1): 17-24. 
23. N'Dao CT, N'Diaye JL, Gaye A, Le Hesran JY. Placental 
malaria and pregnancy outcome in a peri urban area 
in Senegal. Rev Epidemiol Sante Publique 2006; 
54(2): 149-156. 
 
